Notice Number: NOT-17-HL-534

Key Dates
Release Date: August 14, 2017

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective with the October 5, 2017, standard due date, in PA-16-043 "Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01)".

The following sections of PA-16-043 have been updated to reflect the participation of NHLBI in this
Funding Opportunity Announcement (FOA):

Part 1. Overview Information

Components of Participating Organizations
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK))
National Institute of Mental Health (NIMH)
Office of Behavioral and Social Sciences Research (OBSSR)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.399; 93.286; 93.847; 93.173; 93.242, 93.837, 93.838, 93.839, 93.840, 93.233

Section VII. Agency Contacts

Scientific/Research Contact(s)
Erin Iturriaga, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0550
Email: [email protected]

Financial/Grants Management Contact(s)
Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8014
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Erin Iturriaga, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0550
Email: [email protected]